![1]()
News
New heart failure trial data presage guideline revisions
December 9, 2019
PHILADELPHIA – Recent trial findings for sacubitril/valsartan and dapagliflozin in heart failure patients provide a blueprint for guideline changes.
![1]()
News
Aspirin plus a DOAC may do more harm than good in some
December 8, 2019
Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication increased bleeding risks in a large cohort.
![1]()
News
Influenza already in midseason form
December 6, 2019
High levels of flu activity haven’t been seen this early since 2009-2010.
![1]()
News
Experts bring clarity to end of life difficulties
December 5, 2019
Confusing situations sometimes arise when treating patients near the end of their lives.
![1]()
News
Gunshot wound victims are at high risk for readmission
December 4, 2019
CHICAGO – Long-term outcomes of gun violence are still largely unknown.
![1]()
News
2019-2020 flu season starts off full throttle
December 2, 2019
Five states and Puerto Rico already are at the highest level of flu activity, the CDC reports.
![1]()
News
Anticipating the A.I. revolution
November 26, 2019
Hospitalists should be ready for the arrival of artificial intelligence.
![1]()
News
DAPA-HF: Dapagliflozin benefits regardless of age, HF severity
November 25, 2019
PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.
![1]()
News
Large population-based study underscores link between gout, CVD event risk
November 23, 2019
ATLANTA – The relationships between gout and fatal and nonfatal CVD events found in a large population-based health data linkage study in New Zealand were not ameliorated by allopurinol use or serum urate lowering to treatment target.
News
What’s new in hepatitis C: Four themes that dominated at the Liver Meeting
November 22, 2019
BOSTON – AASLD highlights included treatment of persons who inject drugs, new directions in pangenotypic therapy, benefits of sustained virologic response, preemptive therapy in donor-positive organ transplant.
